File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.lfs.2024.123232
- Scopus: eid_2-s2.0-85209240315
- Find via

Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: The roles of pyroptosis in the pathogenesis of autoimmune diseases
| Title | The roles of pyroptosis in the pathogenesis of autoimmune diseases |
|---|---|
| Authors | |
| Keywords | Autoimmune diseases Immune Inflammasome Mechanism Pyroptosis |
| Issue Date | 15-Dec-2024 |
| Publisher | Elsevier |
| Citation | Life Sciences, 2024, v. 359 How to Cite? |
| Abstract | The occurrence of autoimmune diseases is a result of the immune system's immune response against healthy components of the body. Pyroptosis is an innovative form of programmed cell death dependent on inflammatory caspases, leading to the release of cytokines. Excessive pyroptosis can lead to a sustained inflammatory response, which may aggravate the development of autoimmune diseases. In rheumatoid arthritis (RA), tumor necrosis factor (TNF) and NLRP3 enhance pyroptosis, exacerbating the disease. In systemic lupus erythematosus (SLE), the release of nuclear antigen promotes the development of SLE. In multiple sclerosis (MS), elevated active caspase-11 in primary astrocytes induces oligodendrocyte pyroptosis, advancing MS progression. This review outlines the mechanisms of pyroptosis in autoimmune diseases. Meanwhile, we elaborated the possible therapeutic targets from the perspective of pyroptosis. We conclude that pyroptosis is expected to be a therapeutic target for autoimmune diseases. |
| Persistent Identifier | http://hdl.handle.net/10722/362487 |
| ISSN | 2023 Impact Factor: 5.2 2023 SCImago Journal Rankings: 1.257 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Song, Yingqiu | - |
| dc.contributor.author | Peng, Yanhui | - |
| dc.contributor.author | Wang, Bing | - |
| dc.contributor.author | Zhou, Xinyue | - |
| dc.contributor.author | Cai, Yikang | - |
| dc.contributor.author | Chen, Haiyong | - |
| dc.contributor.author | Miao, Chenggui | - |
| dc.date.accessioned | 2025-09-24T00:51:56Z | - |
| dc.date.available | 2025-09-24T00:51:56Z | - |
| dc.date.issued | 2024-12-15 | - |
| dc.identifier.citation | Life Sciences, 2024, v. 359 | - |
| dc.identifier.issn | 0024-3205 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/362487 | - |
| dc.description.abstract | The occurrence of autoimmune diseases is a result of the immune system's immune response against healthy components of the body. Pyroptosis is an innovative form of programmed cell death dependent on inflammatory caspases, leading to the release of cytokines. Excessive pyroptosis can lead to a sustained inflammatory response, which may aggravate the development of autoimmune diseases. In rheumatoid arthritis (RA), tumor necrosis factor (TNF) and NLRP3 enhance pyroptosis, exacerbating the disease. In systemic lupus erythematosus (SLE), the release of nuclear antigen promotes the development of SLE. In multiple sclerosis (MS), elevated active caspase-11 in primary astrocytes induces oligodendrocyte pyroptosis, advancing MS progression. This review outlines the mechanisms of pyroptosis in autoimmune diseases. Meanwhile, we elaborated the possible therapeutic targets from the perspective of pyroptosis. We conclude that pyroptosis is expected to be a therapeutic target for autoimmune diseases. | - |
| dc.language | eng | - |
| dc.publisher | Elsevier | - |
| dc.relation.ispartof | Life Sciences | - |
| dc.subject | Autoimmune diseases | - |
| dc.subject | Immune | - |
| dc.subject | Inflammasome | - |
| dc.subject | Mechanism | - |
| dc.subject | Pyroptosis | - |
| dc.title | The roles of pyroptosis in the pathogenesis of autoimmune diseases | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1016/j.lfs.2024.123232 | - |
| dc.identifier.scopus | eid_2-s2.0-85209240315 | - |
| dc.identifier.volume | 359 | - |
| dc.identifier.eissn | 1879-0631 | - |
| dc.identifier.issnl | 0024-3205 | - |
